Genprex, Inc. Common Stock (GNPX) is a publicly traded Healthcare sector company. As of May 20, 2026, GNPX trades at $0.79 with a market cap of $8.39M and a P/E ratio of -0.04. GNPX moved -1.47% today. Year to date, GNPX is -56.12%; over the trailing twelve months it is -94.52%. Its 52-week range spans $0.74 to $198.50. Rallies surfaces GNPX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
GNPX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. GNPX recently traded at $0.79. Market cap is $8.39M. P/E ratio is -0.04. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $0.79 |
| Market Cap | $8.39M |
| P/E Ratio | -0.04 |
| EPS | $-17.40 |
| Dividend Yield | 0.00% |
| 52-Week High | $198.50 |
| 52-Week Low | $0.74 |
| Volume | 211.51K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-16.23M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $0 | $-16.23M | $-17.40 |
| 2024 | $0 | $-21.11M | $-5.34 |
| 2023 | $0 | $-30.86M | $-22.56 |
| 2022 | $0 | $-23.74M | $-0.50 |
GNPX analyst coverage data. Average price target: $0.00.